Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban

被引：36
作者：
Martinelli, Ida [1 ]
Abbattista, Maria [1 ]
Bucciarelli, Paolo [1 ]
Tripodi, Armando [1 ,2 ]
Artoni, Andrea [1 ]
Gianniello, Francesca [1 ]
Novembrino, Cristina [1 ,2 ,3 ]
Peyvandi, Flora [1 ,2 ,3 ,4 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Univ Milan, Lab Clin Chem & Microbiol, Milan, Italy
[4] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 07期
关键词：
WARFARIN; PREVENTION; ANTICOAGULANTS; INTENSITY; DISEASE; TRIAL; ISTH; SSC;
D O I：
10.3324/haematol.2017.185132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E315 / E317
页数：3
相关论文
共 15 条
[1]  
[Anonymous], 2017, LANCET
[2]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[3]   Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial [J].
Cohen, Hannah ;
Hunt, Beverley J. ;
Efthymiou, Maria ;
Arachchillage, Deepa R. J. ;
Mackie, Ian J. ;
Clawson, Simon ;
Sylvestre, Yvonne ;
Machin, Samuel J. ;
Bertolaccini, Maria L. ;
Ruiz-Castellano, Maria ;
Muirhead, Nicola ;
Dore, Caroline J. ;
Khamashta, Munther ;
Isenberg, David A. .
Lancet Haematology, 2016, 3 (09) :E426-E436
[4]   A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome [J].
Crowther, MA ;
Ginsberg, JS ;
Julian, J ;
Denburg, J ;
Hirsh, J ;
Douketis, J ;
Laskin, C ;
Fortin, P ;
Anderson, D ;
Kearon, C ;
Clarke, A ;
Geerts, W ;
Forgie, M ;
Green, D ;
Costantini, L ;
Yacura, W ;
Wilson, S ;
Gent, M ;
Kovacs, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1133-1138
[5]   Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH [J].
Devreese, K. M. J. ;
Pierangeli, S. S. ;
De Laat, B. ;
Tripodi, A. ;
Atsumi, T. ;
Ortel, T. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (05) :792-795
[6]   Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature [J].
Dufrost, Virginie ;
Risse, Jessie ;
Zuily, Stephane ;
Wahl, Denis .
CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (12)
[7]   A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS) [J].
Finazzi, G ;
Marchioli, R ;
Brancaccio, V ;
Schinco, P ;
Wisloff, F ;
Musial, J ;
Baudo, F ;
Berrettini, M ;
Testa, S ;
D'Angelo, A ;
Tognoni, G ;
Barbui, T .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) :848-853
[8]  
Haladyj Ewa, 2016, Reumatologia (Warsaw), V54, P146, DOI 10.5114/reum.2016.61217
[9]   Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH [J].
Kaatz, S. ;
Ahmad, D. ;
Spyropoulos, A. C. ;
Schulman, S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (11) :2119-2126
[10]   The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome [J].
Malec, Katarzyna ;
Goralczyk, Tadeusz ;
Undas, Anetta .
THROMBOSIS RESEARCH, 2017, 152 :93-97
12